MedTrace Logo

Endoscopy Screening for Esophageal Cancer

NCT00927446 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2010-10-19

No results posted yet for this study

Summary

Patients with head and neck cancer frequently develop synchronous or metachronous esophageal malignancies. Previous studies have demonstrated the efficacy of endoscopic screening for esophageal cancer in head and neck cancer patients. The Narrow Band Imaging (NBI) system, an optical technology that enhances the visualization of superficial vascular network, may be superior to the conventional white light endoscopy for the detection of neoplastic lesions. However, whether the application of NBI improves the detection results have not been critically evaluated.

This study aims to investigate the diagnostic value of the NBI system in the endoscopic screening for esophageal neoplastic lesions in patients with head and neck cancer.

Conditions

Interventions

PROCEDURE

Endoscopy screening with narrow band imaging

Narrow Band Imaging (NBI) system, an optical technology that enhances the visualization of superficial vascular network, may be superior to the conventional white light endoscopy for the detection of neoplastic lesions.

Sponsors & Collaborators

  • Lotung Poh-Ai Hospital

    lead OTHER

Principal Investigators

  • Tzeng-Huey Yang, M.D. · Lotung Poh-Ai Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00927446 on ClinicalTrials.gov